Trial Profile
Retrospective study of dimethyl fumarate (DMF; gastro-resistant) in patients with multiple sclerosis.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 21 Nov 2016
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 26 Feb 2016 New trial record